INVO Bioscience (INVO)
NASDAQ:INVO
US Market

INVO Bioscience (INVO) Stock Price & Analysis

69 Followers

INVO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.30 - $1.65
Previous Close$0.3
Volume102.70K
Average Volume (3M)195.26K
Market Cap
$4.19M
Enterprise Value$3.85M
Total Cash (Recent Filing)$2.19M
Total Debt (Recent Filing)$1.84M
Price to Earnings (P/E)-0.3
Beta1.66
Aug 14, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.87
Shares Outstanding13,971,283
10 Day Avg. Volume56,351
30 Day Avg. Volume195,263
Standard Deviation0.24
R-Squared0.08
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)52.12
Price to Sales (P/S)14.10
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.02
Enterprise Value/Gross Profit7.19
Enterprise Value/Ebitda-0.78
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

INVO FAQ

What was INVO Bioscience’s price range in the past 12 months?
INVO Bioscience lowest stock price was $0.30 and its highest was $1.65 in the past 12 months.
    What is INVO Bioscience’s market cap?
    Currently, no data Available
    When is INVO Bioscience’s upcoming earnings report date?
    INVO Bioscience’s upcoming earnings report date is Aug 14, 2023 which is in 76 days.
      How were INVO Bioscience’s earnings last quarter?
      Currently, no data Available
      Is INVO Bioscience overvalued?
      According to Wall Street analysts INVO Bioscience’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does INVO Bioscience pay dividends?
        INVO Bioscience does not currently pay dividends.
        What is INVO Bioscience’s EPS estimate?
        INVO Bioscience’s EPS estimate is -$0.21.
          How many shares outstanding does INVO Bioscience have?
          INVO Bioscience has 13,971,283 shares outstanding.
            What happened to INVO Bioscience’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of INVO Bioscience?
            Currently, no hedge funds are holding shares in INVO

            ---

            INVO Bioscience Stock Smart Score

            N/A
            Not Ranked
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Technicals

            SMA
            Negative
            20 days / 200 days
            Momentum
            -71.15%
            12-Months-Change

            Fundamentals

            Return on Equity
            -375.77%
            Trailing 12-Months
            Asset Growth
            -27.81%
            Trailing 12-Months
            This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
            Learn more about TipRanks Smart Score

            Company Description

            INVO Bioscience

            INVO BioScience, Inc. focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Medford, MA.

            ---

            Top 5 ETFs holding INVO

            Currently, no data available
            Please return soon. This page is being updated.
            Up to five ETFs with an Outperform Smart Score that hold INVO. The ETFs are listed according to market value of INVO within the ETF

            ---

            Forecast EPS vs Actual EPS

            Currently, no data available
            Please return soon. This page is being updated.

            Similar Stocks
            Company
            Price & Change
            Follow
            Bluejay Diagnostics
            Tivic Health Systems
            Invacare
            Neurometrix
            Brain Scientific

            Popular Stocks

            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis